HILITE—A tool to investigate interactions of matter and light

Detailed investigations of laser–ion interactions require well-defined ion targets and detection techniques for high-sensitivity measurements of reaction educts and products. To this end, we have designed and built the High-Intensity Laser-Ion Trap Experiment Penning trap setup, which features various ion-target preparation techniques including selection, cooling, compression, and positioning as well as destructive and non-destructive measurement techniques to determine the number of stored ions for all charge states individually and simultaneously. We have recently performed first commissioning experiments of ion deceleration and dynamic ion capture with highly charged ion bunches from an electron beam ion source. We have characterized our single-pass non-destructive ion counter in detail and were able to determine the ion velocity as well as the number of ions from the signals acquired.     

Towards experiments with highly charged ions at HESR

The atomic physics collaboration SPARC is a part of the APPA pillar at the future Facility for Antiproton and Ion Research. It aims at atomic-physics research across virtually the full range of atomic matter. An emphasis of this contribution are the atomic physics experiments addressing the collision dynamics in strong electro-magnetic fields as well as the fundamental interactions between electrons and heavy nuclei at the HESR. Here we give a short overview about the central instruments for SPARC experiments at this storage ring.     

Solubility and Crystallizability: Facile Access to Functionalized π‐Conjugated Compounds with Chlorendylimide Protecting Groups

Functional π‐conjugated molecules are relevant for the preparation of new organic electronic materials with improved performance. However, their synthesis is often rendered difficult by their inherently low solubility, and the permanent attachment of solubilizing groups may change the properties of the material. Here, we introduced the chlorendylimidyl moiety as a new temporary protecting group for the straightforward large‐scale synthesis of protected quarter‐, sexi‐, octathiophene, and perylene bisimide diamine and dicarboxylic acid derivatives. The obtained chlorendylimides and chlorendylimidyl active esters were highly soluble in organic solvents, and optical spectroscopy confirmed the low tendency of the compounds to aggregate in solution. At the same time, they could be conveniently purified by recrystallization or precipitation. Single‐crystal X‐ray structures obtained for most compounds showed supramolecular motifs highlighting the role of the rigid, polychlorinated chlorendyl moieties in their crystallization. The obtained protected diamine and dicarboxylic acid derivatives were easily deprotected and converted into various amide‐substituted oligothiophenes and perylene bisimides that are of interest as new functional materials for organic electronic thin film or nanowire devices.     

Azasugar inhibitors as pharmacological chaperones for Krabbe disease

Krabbe disease is a devastating neurodegenerative disorder characterized by rapid demyelination of nerve fibers. This disease is caused by defects in the lysosomal enzyme β-galactocerebrosidase (GALC), which hydrolyzes the terminal galactose from glycosphingolipids. These lipids are essential components of eukaryotic cell membranes: substrates of GALC include galactocerebroside, the primary lipid component of myelin, and psychosine, a cytotoxic metabolite. Mutations of GALC that cause misfolding of the protein may be responsive to pharmacological chaperone therapy (PCT), whereby small molecules are used to stabilize these mutant proteins, thus correcting trafficking defects and increasing residual catabolic activity in cells. Here we describe a new approach for the synthesis of galacto-configured azasugars and the characterization of their interaction with GALC using biophysical, biochemical and crystallographic methods. We identify that the global stabilization of GALC conferred by azasugar derivatives, measured by fluorescence-based thermal shift assays, is directly related to their binding affinity, measured by enzyme inhibition. X-ray crystal structures of these molecules bound in the GALC active site reveal which residues participate in stabilizing interactions, show how potency is achieved and illustrate the penalties of aza/iminosugar ring distortion. The structure–activity relationships described here identify the key physical properties required of pharmacological chaperones for Krabbe disease and highlight the potential of azasugars as stabilizing agents for future enzyme replacement therapies. This work lays the foundation for new drug-based treatments of Krabbe disease.